127 related articles for article (PubMed ID: 10146676)
1. A guide to sample size and interim analysis in clinical trials.
Rademaker AW
Contemp Urol; 1994 Feb; 6(2):43-4. PubMed ID: 10146676
[No Abstract] [Full Text] [Related]
2. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
Small DS; Cheng J
Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
[No Abstract] [Full Text] [Related]
3. Discussions.
Vansteelandt S
Biometrics; 2009 Sep; 65(3):686-9; discussion 689-91. PubMed ID: 18759845
[No Abstract] [Full Text] [Related]
4. Using group-sequential analysis to achieve the optimal sample size.
Rogers MS; Chang AM; Todd S
BJOG; 2005 May; 112(5):529-33. PubMed ID: 15842273
[No Abstract] [Full Text] [Related]
5. Basic statistical testing, including interim analysis.
Guzick DS
Semin Reprod Endocrinol; 1996 May; 14(2):133-7. PubMed ID: 8796936
[TBL] [Abstract][Full Text] [Related]
6. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
Jung SH; Ahn C
Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
[TBL] [Abstract][Full Text] [Related]
7. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
Chen X
Stat Med; 2005 May; 24(9):1449-52; author reply 1452. PubMed ID: 15812844
[No Abstract] [Full Text] [Related]
8. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections, by H. Schäfer and H.-H. Müller, Statistics in Medicine 2001; 20: 3741-3751.
Bauer P; Posch M
Stat Med; 2004 Apr; 23(8):1333-4; author reply 1334-5. PubMed ID: 15083486
[No Abstract] [Full Text] [Related]
9. The prevalence of underpowered randomized clinical trials in rheumatology.
Keen HI; Pile K; Hill CL
J Rheumatol; 2005 Nov; 32(11):2083-8. PubMed ID: 16265683
[TBL] [Abstract][Full Text] [Related]
10. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
Whitehead J; Matsushita T
Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099
[TBL] [Abstract][Full Text] [Related]
11. ALS issues in clinical trials. Missing data.
Thompson JL; Levy G
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
[No Abstract] [Full Text] [Related]
12. Issues in the planning and conduct of randomised trials.
Bhandari M; Pape HC; Giannoudis PV
Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
[TBL] [Abstract][Full Text] [Related]
13. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
Atkins DC
Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
[No Abstract] [Full Text] [Related]
15. [Role of the methodology in cluster randomized trials].
Kramar A; Bonnetain F; Mathoulin-Pélissier S
Bull Cancer; 2008 Dec; 95(12):1141-2. PubMed ID: 19108340
[No Abstract] [Full Text] [Related]
16. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
[TBL] [Abstract][Full Text] [Related]
17. Issues in the meta-analysis of cluster randomized trials.
Donner A; Klar N
Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
[TBL] [Abstract][Full Text] [Related]
18. A practical limit to trials needed in one-person randomized controlled experiments.
Alemi R; Alemi F
Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
[TBL] [Abstract][Full Text] [Related]
19. The role of sampling in clinical trial design.
Krause M; Lutz W; Boehnke JR
Psychother Res; 2011 May; 21(3):243-51. PubMed ID: 21347979
[TBL] [Abstract][Full Text] [Related]
20. Re: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
Shrier I
Stat Med; 2008 Jun; 27(14):2740-1; author reply 2741-2. PubMed ID: 18069729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
